Yep - I'm not much deeper in CVM as regards numbers of shares that I hold. I only do biotechs in a small way because they are inherently risky. Most of what money I invest goes into boring index funds and dividend producers.
That being said - with the Phase III done and at least one wing of the study looking pretty positive - I think most of the risk here is gone for CVM.
IF CVM goes to north of $100/share within the next year (assuming the BLA gets submitted by early-mid 2022), then we both get to decide what to do with our gambling winnings. I'll probably sell about a third of what I hold now and buy some other boring dividend producer with the money, make sure to save some for the long-term capital gains taxes, and let the rest ride for a while.
News 
Market Data 
Discover 
